Netherlands· NL-a24f96719033
Ofloxacine Stulln Unit Dose 3 mg/ml oogdruppels, oplossing
A ofloxacin product containing ofloxacine, registered in Netherlands by Pharma Stulln GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Ofloxacin is registered in 11 of 19 countries.
Countries holding a registration under ATC S01AE01 (ofloxacin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 6 of them publish a price we can compare per daily dose
Ofloxacin · ATC S01AE01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- OFLOXACINE
- Manufacturer
- Pharma Stulln GmbH
- Country
- Netherlands (NL)
- ATC code
- S01AE01
- ATC class
- Ofloxacin
- Defined daily dose
- 0.4 mg, AT
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id109912
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ofloxacin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesOCUFLOXAllergan, Inc.
- PolandFloxalMedezin Sp. z o.o.
- BelgiumOfloxacin-Pos 3 mg/mlURSAPHARM Benelux
- CzechiaFLOXALDr. Gerhard Mann, Chem.- pharm. Fabrik GmbH, Berlín
- FinlandExocinParanova Oy
- FranceMONOOX 1,5 mg/0,5 ml, collyre en solution en récipient unidoseHORUS PHARMA
- SwedenOfloxacin mibe 3 mg/ml Ögondroppar, lösningmibe GmbH Arzneimittel
- United KingdomExocin 0.3% eye dropsNecessity Supplies Ltd
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Floxal, Floxal Edo
- Belgium · Trafloxal, Trafloxal Edo
- Bulgaria · Медофлоксин, Офлоксацин Дра
- Cyprus · Cilox, Medofloxine
- Czechia · Floxal, Ofloxacin Unimed Pharma
- Germany · Floxal, Floxal Edo
- Estonia · Medofloxine, Ofloxin
- Spain · Exocin, Oflovir
- Finland · Exocin
- France · Exocine, Monoflocet
- United Kingdom (Northern Ireland) · Exocin, Ofloxacin Bristol Laboratories
- Greece · Exocin, Oxatrex
- Croatia · Uniflox
- Hungary · Floxal, Grenis-Oflo
- Ireland · Exocin
- Italy · Dunaflot, Exocin
- Lithuania · Ofloxin, Uniflox
- Luxembourg · Ofloxa-Vision Kombi-Packung, Visioflox
- Latvia · Ofloxin, Uniflox
- Malta · Uniflox Unimed Pharma
- Poland · Floxal, Oflodinex
- Portugal · Audret, Bioquil
- Romania · Floxal, Ofloxacină Laropharm
- Sweden · Ofloxacin Mibe
- Slovakia · Medofloxine, Ofloxin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b3297cf5-b8e2-4042-8ff3-cf37c158e53a GET /v1/drugs/b3297cf5-b8e2-4042-8ff3-cf37c158e53a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oogdruppels, oplossing",
"route": "Oculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h109912_smpc.pdf",
"strength": null,
"atc_label": "Ofloxacin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg109912",
"excipients": [
"NATRIUMCHLORIDE",
"NATRIUMHYDROXIDE (E 524)",
"STIKSTOF (HEAD SPACE) (E 941)",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"OFLOXACINE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h109912.pdf",
"authorised_at": "2012/11/26",
"procedure_number": "NL/H/2393/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "109912",
"additional_monitoring": "N"
}See everything about ofloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.